Antipneumocystis activity of 17C91, a prodrug of atovaquone.
The prophylactic efficacy of 17C91, a carbamate prodrug of atovaquone (ATQ), was investigated in a severe combined immunodeficient mouse model of Pneumocystis carinii pneumonia (PCP). At an oral dosage equivalent to 100 mg of ATQ per kg of body weight per day, 17C91 protected 9 of 10 mice from PCP a...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1995
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162917/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8619570/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.10.2217 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|